D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
RETA holding history
Reata Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RETA overviewAll 13F holders of RETAFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −6,075−100.0% | Sold out | Holders |
| Q2 2023 | 6,075 | $619.4K | <0.1% | −87,341−93.5% | Reduced | Holders |
| Q1 2023 | 93,416 | $8.49M | <0.1% | −228,467−71.0% | Reduced | Holders |
| Q4 2022 | 321,883 | $12.2M | <0.1% | +156,053+94.1% | Added | Holders |
| Q3 2022 | 165,830 | $4.17M | <0.1% | −93,825−36.1% | Reduced | Holders |
| Q2 2022 | 259,655 | $7.89M | <0.1% | +203,765+364.6% | Added | Holders |
| Q1 2022 | 55,890 | $1.83M | <0.1% | +7,761+16.1% | Added | Holders |
| Q4 2021 | 48,129 | $1.27M | <0.1% | +48,129 | New | Holders |